Clinical trial
Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer
NCT00079625 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00079625 |
|---|---|
| Title | Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer |
| Official title | Allogeneic Breast Protocol 2: Phase I Trial of T Cell Exchange With Th2/Tc2 Cells for Allogeneic Stem Cell Transplantation After Reduced Intensity Conditioning for Metastatic Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Th2/Tc2 Cells |
| Enrollment | 22 |
| Start date | Mar 5, 2004 |
| Primary completion | Aug 9, 2013 |
| Completion | Aug 9, 2013 |
| First posted | Mar 10, 2004 |
| Last update posted | Jul 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: